152 related articles for article (PubMed ID: 33361514)
1. [Molecular Mechanism Underlying the Function and Disintegration of the Central Nerve System Barrier Unraveled by Proteo-typing of Membrane Proteins].
Terasaki T
Brain Nerve; 2021 Jan; 73(1):59-78. PubMed ID: 33361514
[TBL] [Abstract][Full Text] [Related]
2. Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs.
Takeuchi H; Suzuki M; Goto R; Tezuka K; Fuchs H; Ishiguro N; Terasaki T; Braun C; Uchida Y
Pharm Res; 2022 Jul; 39(7):1393-1413. PubMed ID: 35488144
[TBL] [Abstract][Full Text] [Related]
3. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T
Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
[TBL] [Abstract][Full Text] [Related]
5. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
Zhang Z; Tachikawa M; Uchida Y; Terasaki T
Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
[TBL] [Abstract][Full Text] [Related]
6. Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.
Yaguchi Y; Tachikawa M; Zhang Z; Terasaki T
Mol Pharm; 2019 May; 16(5):2021-2027. PubMed ID: 30977661
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery.
Huttunen KM; Terasaki T; Urtti A; Montaser AB; Uchida Y
Pharm Res; 2022 Jul; 39(7):1363-1392. PubMed ID: 35257288
[TBL] [Abstract][Full Text] [Related]
8. A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance.
Uchida Y; Takeuchi H; Goto R; Braun C; Fuchs H; Ishiguro N; Takao M; Tano M; Terasaki T
J Neurochem; 2022 Apr; 161(2):187-208. PubMed ID: 35226354
[TBL] [Abstract][Full Text] [Related]
9. Unmasking the Role of Uptake Transporters for Digoxin Uptake Across the Barriers of the Central Nervous System in Rat.
Taskar KS; Mariappan TT; Kurawattimath V; Singh Gautam S; Radhakrishna Mullapudi TV; Sridhar SK; Kallem RR; Marathe P; Mandlekar S
J Cent Nerv Syst Dis; 2017; 9():1179573517693596. PubMed ID: 28469522
[TBL] [Abstract][Full Text] [Related]
10. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
Betterton RD; Davis TP; Ronaldson PT
Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Proteomics-Based Blood-Brain Barrier Study.
Uchida Y
Biol Pharm Bull; 2021; 44(4):465-473. PubMed ID: 33790097
[TBL] [Abstract][Full Text] [Related]
12. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
Wang Q; Zuo Z
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
[TBL] [Abstract][Full Text] [Related]
13. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
[TBL] [Abstract][Full Text] [Related]
14. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
Ohtsuki S
Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
[TBL] [Abstract][Full Text] [Related]
15. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
[TBL] [Abstract][Full Text] [Related]
16. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
Tachikawa M; Uchida Y; Terasaki T
Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
[TBL] [Abstract][Full Text] [Related]
17. Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging.
Ichikawa H; Itoh K
Brain Res; 2011 May; 1390():142-9. PubMed ID: 21435335
[TBL] [Abstract][Full Text] [Related]
18. Barrier function in the peripheral and central nervous system-a review.
Reinhold AK; Rittner HL
Pflugers Arch; 2017 Jan; 469(1):123-134. PubMed ID: 27957611
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
[TBL] [Abstract][Full Text] [Related]
20. Drug efflux transporters in the CNS.
Sun H; Dai H; Shaik N; Elmquist WF
Adv Drug Deliv Rev; 2003 Jan; 55(1):83-105. PubMed ID: 12535575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
